Director, Global Product Strategy - Lung Cancer Therapies

Position Summary

We are seeking a strategic, science-driven leader to join our Global Product Strategy team as Director, Lung Cancer Portfolio reports to VP, Lung Cancer Therapies. This position plays a pivotal role in shaping the future of one of our most commercially and scientifically important oncology indications.

The role will focus heavily on new product planning and early commercial strategy, partnering closely with R&D, clinical, medical, and regulatory teams to inform development decisions and prepare the path to launch. As part of a growing commercial organization with presence in the US and Germany, this position requires hands-on leadership, deep oncology market insight, and a strong understanding of how to position early assets for future success in a competitive global environment.

This is a critical value driver for the company, and the role offers the opportunity to influence the strategic direction of a high-priority solid tumor program with global potential.

Key Responsibilities:

• Lead global commercial strategy development for the lung cancer portfolio, with a focus on indication prioritization, early positioning, and value-focused lifecycle strategy
• Drive new product planning activities from preclinical/early clinical through registrational development, supporting strategic TPP shaping, unmet need assessment, competitive differentiation, and commercial viability
• Partner cross-functionally with R&D, clinical development, translational research, regulatory, and medical affairs to embed commercial perspectives into key decisions
• Lead or co-lead commercial input into early launch readiness planning, with emphasis on evidence strategy, access considerations, and strategic stakeholder engagement
• Contribute to cross-functional governance processes, development strategy forums, and scenario planning efforts
• Support external interactions where needed (e.g., advisory boards, co-development partners, select KOL discussions) in alignment with medical and development leadership
• Work collaboratively across the internal team to ensure that the lung cancer portfolio is progressing in line with both scientific excellence and commercial ambition

Requirements:

• A minimum of 8 years of relevant experience in oncology commercial strategy, new product planning, launch readiness, or asset strategy roles
• Strong track record in solid tumors, ideally with direct or adjacent lung cancer experience
• Significant experience in early-stage commercialization, including product concept shaping, indication assessment, and early launch strategy
• Ability to partner effectively with R&D, including familiarity with oncology clinical trial design, regulatory pathways, and biomarker-driven development
• Demonstrated understanding of the US oncology landscape and stakeholder needs; experience & understanding with EU and other major markets
• Strong scientific acumen combined with a highly strategic mindset and the ability to navigate ambiguity in a pre-commercial environment
• Experience working in global or cross-regional roles, ideally within biotech or fast-paced oncology-focused companies

Preferred Qualifications:

• Advanced degree (PhD, PharmD, MD, or MBA) strongly preferred

Expected Pay Range: $168,100 - $268,700/year + benefits, annual bonus & equity (bonus and equity is variable and dependent on company and individual performance).  *Compensation for the role will depend on several factors, including responsibilities of the job, education, experience, knowledge, skills, and abilities.